Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
483 response sent August 1, 2021
- Pages
- 2
- FEI number
- 1222181
In short: This is Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC's written response to FDA, dated August 1, 2021, for its site (FEI 1222181). It sets out the corrective actions the firm committed to.
Inside this response
This inspection in context
Questions about this response
When was Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC inspected by FDA?
This 483 response is dated August 1, 2021.
How do I get the full 483 response for Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC?
Download the original PDF from FDA Intel for $199, with no subscription. You also get an invoice PDF with the order.